Update on Hodgkin Lymphoma: A Virtual ISHL Event

on March 2 and March 9, 2021

Join the ISHL organizational team and an international panel of speakers to discuss the most recent developments in the field of Hodgkin lymphoma. The virtual educational event aims to provide a comprehensive update on current and emerging concepts.

Watch the recorded sessions

March 2, 2021: Current Standards

16:00 – 18:35 CET

Virtual Session Current Standards

  • 16:00–16:10 CET


    • Paul J. Bröckelmann
    • Andreas Engert
  • 16:10–16:30 CET

    Limited-stage cHL

    • Martin Hutchings
  • 16:30–16:45 CET

    Advanced-stage cHL: Pro up-front BEACOPP variants

    • Peter Borchmann
  • 16:45–17:00 CET

    Advanced-stage cHL: Pro up-front ABVD variants

    • Pier Luigi Zinzani
  • 17:00–17:20 CET


  • 17:20–17:50 CET

    Relapsed & refractory cHL

    • Alison Moskowitz
  • 17:50–18:10 CET

    Elderly patients

    • Jonathan Friedberg
  • 18:10–18:30 CET


    • Dennis Eichenauer
  • 18:30–18:35 CET

    Closing remarks

    • Andreas Engert

March 9, 2021: Emerging Concepts

16:00 – 18:25 CET

Virtual Session Emerging Concepts

  • 16:00–16:10 CET


    • Philippe Armand
    • Dennis Eichenauer
  • 16:10–16:30 CET

    cHL genetics & emerging concepts in response assessment

    • Sven Borchmann
  • 16:30–16:50 CET

    cHL TME & checkpoint inhibition

    • Christian Steidl
  • 16:50–17:10 CET

    Innovative 1st-line therapies

    • Paul J. Bröckelmann
  • 17:10–17:30 CET


  • 17:30–18:00 CET

    Novel drugs & ongoing trials

    • Graham Collins
  • 18:00–18:20 CET

    Cellular cHL therapies

    • Barbara Savoldo
  • 18:20–18:25 CET

    Closing remarks

    • Philippe Armand
  • The time zone for all talks is CET
  • All talks are scheduled to include room for discussion and Q&A
  • All talks are held live and will be recorded for later review on demand

We look forward to welcoming you to what we anticipate to be a highly informative and thought-provoking virtual exchange. There will be the opportunity for you to ask questions to the Register for free now and do not hesitate to contact info@hodgkinsymposum.org in case of any questions.


Prof. Andreas Engert, MD
Symposium and GHSG Chairman

Sven Borchmann, MD
Symposium Secretary

PD Paul J. Bröckelmann, MD
Symposium Secretary

Dennis A. Eichenauer, MD
Symposium Secretary

German Hodgkin Study Group (GHSG)
University Hospital of Cologne
Kerpener Str. 62
D-50924 Köln


We thank the following pharmaceutical companies for supporting our virtual ISHL Event.

Bristol-Meyer-Squib Takeda

Update on Hodgkin Lymphoma Schedule (PDF)

Update on Hodgkin Lymphoma Schedule (PDF)